Research graph
References from Case Report: Takotsubo Syndrome During Long-Term Dasatinib Therapy: A Case Report and Critical Review of Causal Attribution. Local targets link to admitted publications; unresolved targets remain external evidence.
International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.
10.1093/eurheartj/ehy076 · External reference
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
10.1093/eurheartj/ehac244 · External reference
A contemporary update on cancer and takotsubo syndrome.
10.3389/fcvm.2023.1301383 · External reference
Cancer therapy-associated Takotsubo cardiomyopathy: A narrative review of mechanisms, drug associations, and clinical implications.
10.1016/j.ahjo.2026.100723 · External reference
Cardiovascular Toxic Effects of Targeted Cancer Therapies.
10.1056/nejmra1100265 · External reference
10.1186/s40959-019-0042-9 · Admitted local publication
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology—part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias.
10.1093/ehjacc/zuac107 · External reference
Stress-Induced Cardiomyopathy in Cancer Patients.
10.1016/j.amjcard.2017.09.009 · External reference
Takotsubo Cardiomyopathy as Epiphenomenon of Cardiotoxicity in Patients With Cancer: A Meta-summary of Case Reports.
10.1097/fjc.0000000000001026 · External reference
Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature.
10.1186/s12885-017-3384-4 · External reference
Takotsubo Syndrome in a Patient Treated With Sunitinib for Renal Cancer.
10.1200/jco.2012.42.4911 · External reference
Association Between Takotsubo Cardiomyopathy and Axitinib: Case Report and Review of the Literature.
10.1200/jco.2013.48.7280 · External reference
Onset of takotsubo syndrome induced by osimertinib in a patient with lung adenocarcinoma.
10.1016/j.rmcr.2024.102056 · 2024 · External reference
Dasatinib targets c-Src kinase in cardiotoxicity.
10.1016/j.toxrep.2023.04.013 · 2023 · External reference
High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity.
10.1016/j.toxlet.2018.08.003 · External reference
Coronary artery spasms due to tyrosine kinase inhibitors used in chronic myeloid leukemia.
External reference
Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib.
10.1186/s40959-021-00119-6 · External reference
Enhanced Rho-Kinase Activity in Circulating Neutrophils of Patients With Vasospastic Angina: A Possible Biomarker for Diagnosis and Disease Activity Assessment.
10.1016/j.jacc.2011.05.046 · External reference
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity.
10.1016/j.jaccao.2022.06.004 · External reference
CARE Checklist for “Takotsubo Syndrome During Long-Term Dasatinib Therapy: A Case Report and Critical Review of Causal Attribution”.
10.5281/zenodo.22738765 · External reference
